Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christophe Borg

Showing results (21-30 of 224) with videos related to

Pageof 23
Sort By:
Bulletin Du Cancer|October 2, 2019
[Radiologic response assessment in metastatic colorectal cancers]Achille Fabre, Nicolas Badet, Paul Calame, et al.
International Journal of Molecular Sciences|March 4, 2020
The Fate of Th17 Cells is Shaped by Epigenetic Modifications and Remodeled by the Tumor MicroenvironmentElodie Renaude, Marie Kroemer, Romain Loyon, et al.
Expert Opinion on Investigational Drugs|March 28, 2008
Ixabepilone, a novel epothilone analog in the treatment of breast cancerXavier Pivot, Christian Villanueva, Loïc Chaigneau, et al.
Molecular Therapy Oncolytics|September 15, 2016
Tumor control by human cytomegalovirus in a murine model of hepatocellular carcinomaAmit Kumar, Laurie Coquard, Sébastien Pasquereau, et al.
Future Oncology (London, England)|June 26, 2019
Ramucirumab and paclitaxel in patients with gastric cancer and prior trastuzumab: subgroup analysis from RAINBOW studyFerdinando De Vita, Christophe Borg, Gabriella Farina, et al.
European Journal of Medicinal Chemistry|September 10, 2015
Novel aminotetrazole derivatives as selective STAT3 non-peptide inhibitorsJean-René Pallandre, Christophe Borg, Didier Rognan, et al.
Journal of Immunological Methods|November 24, 2016
Fungal peptides from pneumonitis hypersensitivity etiologic agents are able to induce specific cellular immune responseAnne-Pauline Bellanger, Thibaud Lignon, Yann Godet, et al.
Plos One|January 30, 2014
QSOX1 inhibits autophagic flux in breast cancer cellsLaura Poillet, Nicolas Pernodet, Michaël Boyer-Guittaut, et al.
Radiation Oncology (London, England)|July 15, 2024
A comparison of target volumes drawn on arterial and venous phase scans during radiation therapy planning for patients with pancreatic cancer: the PANCRINJ studyFabien Zaidi, Paul Calame, Cédric Chevalier, et al.
Journal of Hepatology|February 14, 2013
Metronomic cyclophosphamide: an alternative treatment for hepatic epithelioid hemangioendotheliomaZaher Lakkis, Stefano Kim, Eric Delabrousse, et al.
Pageof 23

Showing results (21-30 of 224) with videos related to

Sort By:
Pageof 23
Bulletin Du Cancer|October 2, 2019
[Radiologic response assessment in metastatic colorectal cancers]Achille Fabre, Nicolas Badet, Paul Calame, et al.
International Journal of Molecular Sciences|March 4, 2020
The Fate of Th17 Cells is Shaped by Epigenetic Modifications and Remodeled by the Tumor MicroenvironmentElodie Renaude, Marie Kroemer, Romain Loyon, et al.
Expert Opinion on Investigational Drugs|March 28, 2008
Ixabepilone, a novel epothilone analog in the treatment of breast cancerXavier Pivot, Christian Villanueva, Loïc Chaigneau, et al.
Molecular Therapy Oncolytics|September 15, 2016
Tumor control by human cytomegalovirus in a murine model of hepatocellular carcinomaAmit Kumar, Laurie Coquard, Sébastien Pasquereau, et al.
Future Oncology (London, England)|June 26, 2019
Ramucirumab and paclitaxel in patients with gastric cancer and prior trastuzumab: subgroup analysis from RAINBOW studyFerdinando De Vita, Christophe Borg, Gabriella Farina, et al.
European Journal of Medicinal Chemistry|September 10, 2015
Novel aminotetrazole derivatives as selective STAT3 non-peptide inhibitorsJean-René Pallandre, Christophe Borg, Didier Rognan, et al.
Journal of Immunological Methods|November 24, 2016
Fungal peptides from pneumonitis hypersensitivity etiologic agents are able to induce specific cellular immune responseAnne-Pauline Bellanger, Thibaud Lignon, Yann Godet, et al.
Plos One|January 30, 2014
QSOX1 inhibits autophagic flux in breast cancer cellsLaura Poillet, Nicolas Pernodet, Michaël Boyer-Guittaut, et al.
Radiation Oncology (London, England)|July 15, 2024
A comparison of target volumes drawn on arterial and venous phase scans during radiation therapy planning for patients with pancreatic cancer: the PANCRINJ studyFabien Zaidi, Paul Calame, Cédric Chevalier, et al.
Journal of Hepatology|February 14, 2013
Metronomic cyclophosphamide: an alternative treatment for hepatic epithelioid hemangioendotheliomaZaher Lakkis, Stefano Kim, Eric Delabrousse, et al.
Pageof 23